Clinical trial
A Phase III Study of Armodafinil for the Treatment of Cancer-Related Fatigue for Patients With Multiple Myeloma
NCT01160380 is registered in ClinicalTrials.gov with Oncotherapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Study of Armodafinil for the Treatment of Cancer-Related Fatigue for Patients With Multiple Myeloma
- Lead sponsor
- Oncotherapeutics
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- May 31, 2014
- Enrollment
- 50 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.